Benzimidazole

Benzimidazole

SCHEMBL4295899

CC#N.c1ccc2[nH]cnc2c1

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRKCI P41743 1/20 0.46
▸ KDM4E B2RXH2 6/20 0.44
▸ MAPT P10636 2/20 0.44
▸ RAD52 P43351 1/20 0.44
▸ MMP12 P39900 1/20 0.42
▸ SMN1; SMN2 Q16637 3/20 0.41
▸ PARP1 P09874 2/20 0.41
▸ PDPK1 O15530 1/20 0.41
▸ CA12 O43570 1/20 0.41
▸ ALOX15 P16050 1/20 0.41
▸ CA9 Q16790 1/20 0.41
▸ TNKS2 Q9H2K2 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.40
▸ HPGD P15428 3/20 0.40
▸ RAB9A P51151 2/20 0.40
▸ TDP1 Q9NUW8 2/20 0.40
▸ QPCT Q16769 2/20 0.40
▸ QPCTL Q9NXS2 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ HTT P42858 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzimidazole SCHEMBL2971795 0.89 SMN1; SMN2 (0.48) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL2950245 0.89 SMN1; SMN2 (0.48) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL1293052 0.89 SMN1; SMN2 (0.48) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL14722520 0.88 SMN1; SMN2 (0.41) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL14722521 0.88 SMN1; SMN2 (0.41) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL17786061 0.87 KDM4E (0.50) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL10432218 0.87 KDM4E (0.50) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL4441683 0.87 SMN1; SMN2 (0.47) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL7773385 0.87 KDM4E (0.50) PRKCIKDM4EMAPTRAD52MMP12
Benzimidazole SCHEMBL31239694 0.87 SMN1; SMN2 (0.47) PRKCIKDM4EMAPTRAD52MMP12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119751357-A Benzimidazole substituted cyclopentenones compound, and preparation method and application thereof 云南农业大学 2025-04-04 — — CN claimed
CN-117402464-A Blue light-proof composite master batch 上海沪正实业有限公司 2024-01-16 — — CN claimed
CN-109912580-A A kind of Ratiometric fluorescent probe and its preparation method and application 南华大学 2019-06-21 — — CN claimed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 — — US claimed
JP-2007505085-A — — 2007-03-08 — — JP claimed
EP-1667995-A1 BENZIMIDAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 — — EP claimed
WO-2005026155-A1 BENZIMIDAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 — — WO claimed
CN-119751357-A Benzimidazole substituted cyclopentenones compound, and preparation method and application thereof 云南农业大学 2025-04-04 — — CN disclosed
CN-117402464-A Blue light-proof composite master batch 上海沪正实业有限公司 2024-01-16 — — CN disclosed
CN-109912580-A A kind of Ratiometric fluorescent probe and its preparation method and application 南华大学 2019-06-21 — — CN disclosed
CN-109912810-A A kind of preparation method of porous ZIF-7 ball 浙江工业大学 2019-06-21 — — CN disclosed
CN-109912580-A A kind of Ratiometric fluorescent probe and its preparation method and application 南华大学 2019-06-21 — — CN disclosed
CN-108250220-A Phenothiazines coumarine dye and synthetic method with big Stokes displacements 广西师范学院 2018-07-06 — — CN disclosed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 — — US disclosed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 — — US disclosed
US-20070203134-A1 Benzimidazole Acetonitriles APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (NL) 2007-08-30 — — US disclosed
EP-1667995-A1 BENZIMIDAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 — — EP disclosed
EP-1667995-A1 BENZIMIDAZOLE ACETONITRILES Applied Research Systems ARS Holding N.V. (AN) 2006-06-14 — — EP disclosed
WO-2005026155-A1 BENZIMIDAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 — — WO disclosed
WO-2005026155-A1 BENZIMIDAZOLE ACETONITRILES APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2005-03-24 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203134-A1 Benzimidazole Acetonitriles PKD1, GPR119, CCNI PRKCI 1530/4885KDM4E 3530/4885MAPT 4873/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback